[Enzyme immunoassay for pregnancy-specific beta 1-glycoprotein (SP-1) in patients with testicular tumors].

Abstract

The use of a two-side-binding-enzyme-immunoassay for pregnancy-specific beta 1-glycoprotein (SP-1) in tumours of the testicles is described. The lower limit of evidence is with 4 ng/ml near to the physiological region. In 17 of 41 non-seminomatous germinal tumours of the testicles (41%) initially increased SP-1-serum concentrations were present, the other measuring values correlated with the course of the disease. In all tumours of the testicles with initially increased SP-1-titres the use of the SP-1-test gives a further possibility of the regulation of therapy and control of the course.

• Authors: H Schulze, H Schmechta, B Hallmann, J Ruttloff, T Porstmann, B Porstmann
• Journal: Zeitschrift fur Urologie und Nephrologie (Z Urol Nephrol) Vol. 78 Issue 6 Pg. 293-8 (Jun 1985) ISSN: 0044-3611 [Print] Germany
• Vernacular Title: Enzymimmunoassay für schwangerschaftsspezifisches beta 1-Glycoprotein (SP-1) bei Patienten mit Hodentumoren.
• PMID: 2994322 (Publication Type: English Abstract, Journal Article)

Chemical References

• Pregnancy Proteins
• Pregnancy-Specific beta 1-Glycoproteins

Topics

• Adolescent
• Castration
• Choriocarcinoma (diagnosis)
• Combined Modality Therapy
• Dysgerminoma (diagnosis)
• Follow-Up Studies
• Humans
• Immunoenzyme Techniques
• Lymph Node Excision
• Lymphatic Metastasis
• Male
• Neoplasms, Germ Cell and Embryonal (blood, diagnosis, surgery)
• Pregnancy Proteins (metabolism)
• Pregnancy-Specific beta 1-Glycoproteins (metabolism)
• Teratoma (diagnosis)
• Testicular Neoplasms (blood, diagnosis, surgery)